Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Anticipated Size Of The Cross-Species Organ Transplantation Market Over The Five-Year Period 2025–2029?
The cross-species organ transplantation market size has shown significant growth over recent years. This market is anticipated to expand from $13.98 billion in 2024 to $15.20 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.7%. Historically, this expansion has been driven by factors such as animal model experimentation, the emergence of bioethics debates, the rising prevalence of chronic diseases, experimental pig-to-primate transplants, and high mortality from end-stage organ failure.
The cross-species organ transplantation market is projected to experience substantial expansion in the coming years, reaching a valuation of $20.95 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.3%. This anticipated growth is driven by several factors, including the rising need for transplantable organs, increased funding in regenerative medicine, the worldwide prevalence of chronic kidney and liver conditions, patient advocacy for transplant accessibility, and the decreasing supply of human donors. Key trends anticipated during this period encompass the development of gene-edited pig organs, engineering human-compatible genomes, leveraging artificial intelligence for organ matching, the 3D bioprinting of vascular structures, advancements in machine perfusion and preservation technologies, and nanoscale drug delivery methods for managing immunosuppression.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27267&type=smp
What Are The Emerging Market Drivers Creating New Opportunities In The Cross-Species Organ Transplantation Industry?
The increasing adoption of genetic engineering is anticipated to advance the expansion of the cross-species organ transplantation market in the future. This field involves the intentional alteration of an organism’s DNA through biotechnological methods to either insert, eliminate, or change particular genes. The surge in genetic engineering stems from the pressing requirement to tackle the scarcity of organs by developing animal organs with enhanced compatibility for human recipients. It facilitates the progress of cross-species organ transplantation by allowing animal organs to be modified, thereby minimizing immune rejection and rendering them viable for human transplants. An illustrative example is provided by the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, which reported in July 2023 that 247 gene therapies were in Phase II at the close of the first quarter of 2023, subsequently rising by 5% to a total of 260 by the end of the second quarter. Consequently, the expanding adoption of genetic engineering is propelling the development of the cross-species organ transplantation market.
Which Key Segments Fueling The Cross-Species Organ Transplantation Market?
The cross-species organ transplantation market covered in this report is segmented
1) By Product Type: Organ Preservation Solution, Transplant Diagnostics, Xeno Products, Other Product Types
2) By Application: Kidney, Heart, Liver, Lung, Other Applications
3) By End-User: Transplant Centers, Hospitals, Other End-Users
Subsegments:
1) By Organ Preservation Solution: Hypothermic Machine Perfusion (HMP) Solutions, Normothermic Machine Perfusion (NMP) Solutions, Static Cold Storage (SCS) Solutions, Oxygenated Perfusion Solutions
2) By Transplant Diagnostics: Histocompatibility Testing, Crossmatching Tests, Molecular Typing (DNA-based Testing), Immunological Monitoring Assays
3) By Xeno Products: Genetically Engineered Donor Organs, Decellularized Organ Scaffolds, Xenogeneic Cellular Therapies, Immunosuppressive Regimens For Xenotransplants
4) By Other Product Types: Organ Transport Devices, Organ Recovery and Preservation Equipment, Surgical Instruments For Transplantation, Post-Transplant Monitoring Devices
Which Key Trends Are Expected To Influence The Cross-Species Organ Transplantation Market In The Coming Years?
Leading firms within the cross-species organ transplantation market are prioritizing the formation of strategic alliances to expedite the regulatory clearance process for their xenotransplantation offerings. Such a partnership represents a collaborative arrangement where entities collaborate, leveraging their respective strengths and assets to attain shared objectives, thereby fostering expansion, inventive solutions, and market advantage without undergoing a merger. An illustrative example is seen in February 2025, when United Therapeutics, a US-based biotechnology firm, and eGenesis, a US-based pharmaceutical enterprise, commenced clinical trials involving pig kidney (xenotransplant) transplants in human subjects. The U.S. Food and Drug Administration (FDA) granted approval for this specific trial, permitting the transplantation of genetically modified pig kidneys into individuals suffering from kidney failure. These trials endeavor to alleviate the severe scarcity of donor kidneys by potentially supplying a novel and durable source of organs for individuals requiring them.
Which Key Market Players Are Investing In Expansion And Innovation Of Cross-Species Organ Transplantation Market?
Major companies operating in the cross-species organ transplantation market are Pfizer Inc, F. Hoffmann-la Roche Ltd, Sanofi SA, Novartis AG, Optipharm Co Ltd, Astellas Pharma Inc., United Therapeutics Corporation, TransMedics Group Inc., Artivion Inc., eGenesis Inc., Organ Recovery Systems Inc., OrganOX Ltd, Paragonix Technologies Inc., Qihan Biotech, PorMedTec Co., XenoTheraputics Inc., Makana Therapeutics Inc., Preservation Solutions Inc., Nzeno Ltd, Infigen Inc.
Download The Full Report For Exclusive Market Findings:
Which Region Is Projected To Lead The Cross-Species Organ Transplantation Market During The Forecast Period?
North America was the largest region in the cross-species organ transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cross-species organ transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Cross-Species Organ Transplantation Market Report:
https://www.thebusinessresearchcompany.com/customise?id=27267&type=smp
Browse Through More Reports Similar to the Global Cross-Species Organ Transplantation Market 2025, By The Business Research Company
Landscaping Services Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/landscaping-services-global-market-report
Architectural Services Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/architectural-services-global-market-report
Crop Production Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/crop-production-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model